Praxis Precision Medicines, Inc. PRAX
280.78
(1.01)
(0.36%)
as of 25 Sep
- Market cap
- $7.9B
- P/E
- 0.0×
Follow PRAX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
5.05 | 10.03 | 15.66 | 15.46 | |
Current Ratio |
5.18 | 10.22 | 15.88 | 15.73 | |
Net Debt/EBITDA |
3.38 | 6.14 | 7.39 | 7.78 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.88 | 0.86 | 0.93 | 0.93 | |
Capex/Depreciation |
0.00 | 0.00 | 0.10 | 1.55 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.96) | (3.39) | (2.98) | (2.66) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.03) | |
Free Cash Flow per Share |
(2.96) | (3.39) | (2.98) | (2.70) | |
Cash per Share |
12.16 | 26.63 | 27.24 | 26.04 | |
Shareholders Equity per Share |
15.63 | 39.02 | 48.81 | 46.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
15.63 | 39.02 | 48.81 | 46.03 | |
Free Cash Flow |
(65.06) | (76.32) | (86.21) | (78.56) | |
Working Capital |
220.96 | 551.14 | 747.53 | 722.85 | |
Capital Expenditures |
0.00 | 0.00 | (0.06) | (1.02) | |
Net Current Asset Value |
220.96 | 551.14 | 747.53 | 722.85 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
22.91 | 18.58 | 27.03 | 26.11 | |
Average Assets |
406.32 | 710.51 | 969.47 | 921.47 | |
Average Common Equity |
363.09 | 661.79 | 924.59 | 872.63 |
Columns are period end dates